TAK, US8740602052

Takeda stock: Bank of America reiterates Buy rating

Published on 11/17/2026 at 09:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Takeda stock is in focus after Bank of America Securities reiterated a Buy rating. The analyst set an 8,000-yen price target.

Analyst action and investor focus

  • Bank of America Securities reiterated a Buy rating on Takeda on November 16, 2026.
  • The analyst set an 8,000-yen price target for the pharmaceutical company.
TAK, US8740602052, Illustration mit AI erstellt.

Bank of America Securities analyst Koichi Mamegano reiterated a Buy rating on Takeda on November 16, 2026, and set a price target of 8,000 yen, according to Markets Insider, which cited TipRanks.

Analyst Mamegano was described as maintaining a bullish view on Takeda Pharmaceutical Company. The report also said that the broader analyst consensus for Takeda was Strong Buy, with a consensus price target of 46.11 US dollars.

What the rating means for investors

The action gives investors a fresh sell-side assessment of Takeda as the company continues to develop and commercialize medicines across oncology, gastroenterology, inflammation and other therapeutic areas. The rating itself is an analyst view rather than a company announcement, so the price target should be considered alongside Takeda's operating performance, regulatory progress and product launches.

Takeda stock traded at 19.50 euros on Lang & Schwarz at 09:15 CET on Tuesday, November 17, 2026.

The next notable investor event listed in Takeda's recent communications is the company's Capital Markets Day scheduled for December 11, 2026, in Tokyo.

Takeda Pharmaceutical Company

  • Company: Takeda Pharmaceutical Company Limited
  • ISIN: US8740602052
  • Ticker: TAK
  • Lang & Schwarz quote: 19.50 euros at 09:15 CET on November 17, 2026

The broader Japanese market remains relevant for Takeda investors; see current Nikkei 225 market reports.

For more company-specific coverage, see More news and analyses on Takeda stock.

Disclaimer...
en | US8740602052 | TAK | boerse | 70525601 | bgmi